Replacing daily cART with AAV-expressed eCD4-Ig
Saved in:
Main Authors: | M. Gardner (Author), M. Davis-Gardner (Author), M. Farzan (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2019-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Properties of eCD4-Ig relevant to reducing the viral reservior
by: M. Farzan, et al.
Published: (2017) -
eCD4-Ig promotes ADCC activity of sera from HIV-1-infected patients
by: M.E. Davis-Gardner, et al.
Published: (2017) -
OP 6.8 - 00102 In vivo evolution of env in SHIV-AD8-infected rhesus macaques after AAV-eCD4-Ig therapy
by: D. O'Hagan, et al.
Published: (2022) -
Therapeutic efficacy of optimized eCD4-Ig proteins in SHIV-infected rhesus macaques
by: M.R. Gardner, et al.
Published: (2017) -
Pre-cART Immune Parameters in People Living With HIV Might Help Predict CD8+ T-Cell Characteristics, Inflammation Levels, and Reservoir Composition After Effective cART
by: Jimena Salido, et al.
Published: (2021)